Targeted Molecular Immunotherapy Trademark Details

Targeted Molecular Immunotherapy was registered on Tuesday, July 12, 2005 and is currently owned by Globeimmune, Inc. under the registration number 2968947 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 9 years ago on Tuesday, June 30, 2015, according to the United State Patent & Trademark Office
Word Mark Targeted Molecular Immunotherapy
Status Alive Registered 800 — Registered and Renewed

Current Owner

Globeimmune, Inc. of Louisville, CO

View all trademarks for Globeimmune, Inc.
Other Trademarks for Globeimmune, Inc.
Serial Number 78382707
Registration Number 2968947
Status Date Tuesday, June 30, 2015
Filing Date Tuesday, June 30, 2015
Registration Date Tuesday, July 12, 2005
Attorney Sabrina C. Stavish

Correspondent

Sabrina C. Stavish
SHERIDAN ROSS P.C.
SUITE 1200
1560 BROADWAY
DENVER CO 80202

Case File Statements

Certificate of Correction for Registration In the statement, Column 1, line 1, " Colorado" should be deleted, and Delaware should be inserted.
Goods & Services Pharmaceutical Preparations for Treatment of Cancer and Infectious Disease; Therapeutic and Prophylactic Vaccines

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, March 28, 2005
First Use Anywhere Wednesday, February 9, 2005
First Use In Commerce Wednesday, February 9, 2005
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.